Treatments P1: RB Koloors | Number of revertants (M ± DP)/plate and MI | |||
TA98 | TA100 | |||
µL·plate−1 | −S9 | +S9 | −S9 | +S9 |
0.0a | 23 ± 1 | 38 ± 4 | 137 ± 5 | 158 ± 5 |
10.0 | 22 ± 6 (1.0) | 42 ± 3 (1.1) | 110 ± 7 (0.8) | 182 ± 7* (1.2) |
20.0 | 20 ± 2 (0.9) | 39 ± 3 (1.0) | 100 ± 12 (0.7) | 180 ± 4** (1.1) |
40.0 | 21 ± 2 (0.9) | 33 ± 2 (0.9) | 100 ± 10 (1.0) | 178 ± 3** (1.1) |
60.0 | 18 ± 2 (0.8) | 35 ± 3 (0.9) | 102 ± 8 (0.7) | 161 ± 3 (1.0) |
80.0 | 27 ± 3 (1.2) | 32 ± 3 (0.8) | 102 ± 11 (0.7) | 140 ± 9 (0.9) |
Ctrol+ | 756 ± 133b | 2076 ± 61e | 1413 ± 86c | 1437 ± 43e |
| TA102 | TA97a | ||
0.0a | 263 ± 18 | 275 ± 13 | 138 ± 5 | 156 ± 9 |
10.0 | 205 ± 35 (0.8) | 247 ± 5 (0.9) | 110 ± 21 (0.8) | 178 ± 7 (1.1) |
20.0 | 174 ± 7 (0.7) | 246 ± 2 (0.9) | 100 ± 3 (0.7) | 166 ± 6 (1.1) |
40.0 | 181 ± 11 (0.7) | 269 ± 2 (1.0) | 93 ± 6 (0.7) | 150 ± 9 (1.0) |
60.0 | 177 ± 4 (0.7) | 229 ± 3 (0.8) | 98 ± 3 (0.7) | 135 ± 5 (0.9) |
80.0 | 167 ± 2 (0.6) | 226 ± 7 (0.8) | 143 ± 17 (1.0) | 135 ± 5 (0.9) |
Ctrol+ | 1203 ± 79d | 1366 ± 46f | 854 ± 118b | 2405 ± 88e |